| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 245 | 920 | 370 | $60 | $360.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 97 | 820 | 390 | $70 | $245K |
| 90460 | In this procedure, the provider administers a single live attenuated vaccine through a parenteral, oral, intranasal, intramuscular, or intravenous to a patient up to 18 years of age. | 239 | 250 | 660 | $40 | $172.7K |
| 99393 | The provider performs an established well–patient visit for a child who is between the ages of 5 and 11. | 154 | 170 | 500 | $100 | $170.6K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 177 | 310 | 90 | $90 | $136.3K |
| 99394 | The provider performs an established well–patient visit for an adolescent who is between the ages of 12 and 17. | 146 | 160 | 190 | $110 | $129.7K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 67 | 230 | 100 | $110 | $97.1K |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 83 | 160 | 260 | $30 | $54.2K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 84 | 100 | 180 | $40 | $54.2K |
| 87811 | The lab analyst performs the technical lab test to analyze for the presence of severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) (Coronavirus disease [COVID–19]) in a specimen by… | 50 | 50 | 110 | $20 | $33.6K |